Pablo E Vega is a Vega Alta, Puerto Rico based male podiatrist who is specialized in Podiatry. Active license number of Pablo E Vega for Podiatry is 083 in Puerto Rico. Pablo E Vega is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Pablo E Vega speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Male
Practice Address:
The Gallery At Gran Caribe, Suite 205, Vega Alta, Puerto Rico, 00692
Phone:
787-883-4567
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790868610
NPI Enumeration Date:
23 Oct, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Pablo E Vega are as mentioned below.
License Number
Specialization
State
Status
083
Podiatry
Puerto Rico
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 631, Vega Alta, Puerto Rico
Zip:
00692-0631
Phone Number:
787-883-4977
Fax Number:
--
Patients can reach Pablo E Vega at The Gallery At Gran Caribe, Suite 205, Vega Alta, Puerto Rico or can call to book an appointment on 787-883-4567. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.